Clinical Trials Sponsored by Roxane Laboratories

Total 2461 results

Roxane Laboratories

Completed

Safety and Pharmacokinetic Study of Oral Morphine Sulfate in Pediatric Subjects

Pain

United States
Roxane Laboratories

Completed

Bioequivalency Study of Protriptyline 10 mg Tablets Under Fasted Conditions

Depression

United States
Roxane Laboratories

Completed

Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg /25 mg Tablet Under Fed Conditions

Hypertension

United States
Roxane Laboratories

Completed

Bioequivalency Study of Zidovudine Under Fed Conditions

HIV Infections

United States
Roxane Laboratories

Completed

Bioequivalency Study of Zolpidem Tartrate Under Fasting Conditions

Insomnia

United States
Roxane Laboratories

Completed

Bioequivalency Study of 7.5 mg Pilocarpine Under Fed Conditions

Dry Mouth

United States
Roxane Laboratories

Completed

Bioequivalency Study of Montelukast 10 mg Tablets Under Fasted Conditions

Asthma

United States
Roxane Laboratories

Completed

Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fasted Conditions

Hypertension

United States
Roxane Laboratories

Completed

Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fasted Conditions

Asthma

United States
Roxane Laboratories

Completed

Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fed Conditions

Dry Mouth

United States
Roxane Laboratories

Completed

Dose Proportionality and Food Effect of Morphine Sulfate

Pain

United States
Roxane Laboratories

Completed

Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed Conditions

Herpes Zoster | Genital Herpes | Shingles

United States
Roxane Laboratories

Completed

Bioequivalency Study of Zaleplon 10 mg Capsules Under Fed Conditions

Short Term Treatment of Insomnia

United States
Roxane Laboratories

Completed

Bioequivalency Study of Amlodipine Tablets Under Fasting Conditions

Hypertension | Vasospastic Angina | Chronic Stable Angina

United States
Roxane Laboratories

Completed

Bioequivalency Study of Calcitriol Tablets Under Fasting Conditions

Hypocalcemia | Secondary Hyperparathyroidism

United States
Roxane Laboratories

Completed

Bioequivalency Study of 5 mg Pilocarpine Tablets Under Fasting Conditions

Dry Mouth

United States
Roxane Laboratories

Completed

Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fed Conditions

Essential Hypertension

United States
Roxane Laboratories

Completed

Bioequivalency Study of Morphine Sulfate Injection, Solution and Tablet Under Fasted Conditions

Pain

United States
Roxane Laboratories

Completed

Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fed Conditions

Seizures

United States
Roxane Laboratories

Completed

Bioequivalency Study of Exemestane 25 mg Tablet Under Fed Conditions

Breast Cancer

United States
Roxane Laboratories

Completed

Bioequivalency Study of Anastrozole 1 mg Under Fed Conditions

Breast Cancer

United States
Roxane Laboratories

Completed

Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fed Conditions

Migraine

United States
Roxane Laboratories

Completed

Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fed Conditions

Hypertension

United States
Roxane Laboratories

Completed

Bioequivalency Study of 600 mg Oxcarbazepine Tablets Under Fasting Conditions

Epilepsy | Seizures

Canada
Roxane Laboratories

Completed

Bioequivalency Study of Famciclovir 500 mg Tablets Under Fed Conditions

Herpes

United States
Roxane Laboratories

Completed

Bioequivalency Study of Famciclovir 500 mg Tablets Under Fasted Conditions

Herpes

United States
Roxane Laboratories

Completed

Bioequivalency Study of Torsemide Tablets Under Fasting Conditions

Edema

United States
Roxane Laboratories

Completed

Bioequivalency Study of Clarithromycin Tablets Under Fed Conditions

Infection

United States
Roxane Laboratories

Completed

Food Effect Study of Codeine Sulfate

Pain

United States
Roxane Laboratories

Completed

Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fasted Conditions

Essential Hypertension

United States
Roxane Laboratories

Completed

Bioequivalency Study of Buprenorphine Hydrochloride 8 mg Tablet Under Fasted Conditions

Opioid-Related Disorders

United States
Roxane Laboratories

Completed

Bioequivalency Study of Levetiracetam 1g Tablets Under Fed Conditions

Seizures

United States
Roxane Laboratories

Completed

Comparative Bioavailability Study of Codeine Sulfate

Pain

United States
Roxane Laboratories

Completed

Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fasted Conditions

Breast Cancer

United States
Roxane Laboratories

Completed

Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed Conditions

Hypertension

United States
Roxane Laboratories

Completed

Crossover Bioequivalence Study of Tinidazole 500 mg Tablets Under Fed Conditions

Trichomoniasis

United States
Roxane Laboratories

Completed

Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions

Epilepsy | Seizures

United States
Roxane Laboratories

Completed

Pilot Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions

Breast Cancer

United States
Roxane Laboratories

Completed

Bioequivalency Study of 300 mg Lithium Carbonate Under Fed Conditions

Bipolar Disorder

United States
Roxane Laboratories

Completed

A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Granisetron Hydrochloride 1 mg Tablets Under Fed Conditions

Nausea | Vomiting

United States
Roxane Laboratories

Completed

Bioequivalency Study of Mycophenolate Mofetil 250 mg Capsules Under Fed Conditions

Prophylaxis of Organ Rejection

United States
Roxane Laboratories

Completed

Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Tablet Under Fasted Conditions

Hypertension

United States
Roxane Laboratories

Completed

Bioequivalency Study of Sertraline Under Fed Conditions

Depression

Canada
Roxane Laboratories

Completed

Bioequivalency Study of Meloxicam Tablets Under Fed Conditions

Inflammation

United States
Roxane Laboratories

Completed

Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fasted Conditions

Treatment for Bipolar I Disorder

United States
Roxane Laboratories

Completed

Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fasted Conditions

Hypertension

United States
Roxane Laboratories

Completed

Steady State Study of Codeine Sulfate

Pain

United States
Roxane Laboratories

Completed

Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fed Conditions

Asthma

United States
Roxane Laboratories

Completed

Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fasted Conditions

Migraine

United States
Roxane Laboratories

Completed

Bioequivalency Study of 300 mg Lithium Carbonate Under Fasting Conditions

Bipolar Disorder

United States

3

Subscribe